To address this, we tested the two NR5A1 variants on their ability to upregulate the Sox9 enhancer mTESCO, as well as a previously characterized loss of function variant (p.Arg84His) from a 46,XY DSD patient as a positive control (Robevska et al., 2018). The gene discussed is SOX9; the disease is disorder of sexual differentiation.